November 09, 2026
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: Osteoarthritis Therapeutics Market worth $11.0 billion by 2025 – Rising number of sports injuries.
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Press Releases > Osteoarthritis Therapeutics Market worth $11.0 billion by 2025 – Rising number of sports injuries.
Press Releases

Osteoarthritis Therapeutics Market worth $11.0 billion by 2025 – Rising number of sports injuries.

By Newsroom
Last updated: August 5, 2021
3 Min Read
Share


(I-BusinessNews.Com, August 05, 2021 ) The Global Osteoarthritis Therapeutics Market is projected to reach USD 11.0 billion by 2025 from USD 7.3 billion in 2020, at a CAGR of 8.7% from 2020 to 2025. The growth of this market is driven by significant adoption of pain medications, increasing prevalence of osteoarthritis, growing population susceptible to osteoarthritis, and rising number of sports injuries.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209565994

OPPORTUNITY: Personalized medicine for osteoarthritis

Remarkable advances have been made in diagnosing, treating, and monitoring disease activity in patients with osteoarthritis, including the conceptualization of personalized OA medications. Essential features of biomarkers that will have clinical relevance for a personalized approach to therapy for RA include the ease of measurement, acceptable levels of sensitivity and specificity, and test methods that are accessible and interpretable by clinicians. The use of biomarkers to identify patients who are likely to respond to specific medical therapies may increase treatment response rates and reduce the risk of exposure to therapies that are unlikely to be effective or expose patients to serious treatment-related side-effects. The combination of unique biomarkers and baseline clinical characteristics such as sex and age may further enhance efforts to personalize treatment regimens for RA. 

“Europe commanded the largest share of the osteoarthritis therapeutics market in 2020.”

On the basis of region, the osteoarthritis therapeutics market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2019, Europe commanded the largest share of the osteoarthritis therapeutics market. The large share of this market segment can be attributed to the rising incidence of osteoarthritis, rising geriatric population, and increasing obesity rates in several European countries, coupled with the rising number of injuries due to sports and road accidents. 

Key Market Players

The major players operating in this market are Sanofi (France), Horizon Therapeutics PLC (Ireland), Johnson & Johnson (US), GlaxoSmithKline PLC (UK), Bayer AG (Germany), Abbott (US), Pfizer, Inc. (US), Eli Lilly (US), Anika Therapeutics, Inc. (US), Novartis AG (Switzerland), Ferring Pharmaceuticals (Switzerland), Bioventus (US), Zimmer Biomet Holdings, Inc. (US), Fidia Farmaceutici s.p.a. (Italy), Flexion Therapeutics, Inc. (US), Pharmed Limited (India), Virchow Biotech (India), Kitov Pharmaceuticals Ltd. (Israel), Assertio Therapeutics, Inc. (US), Atnahs (UK), Almatica Pharma LLC (US), OrthogenRx (US), LABRHA (France), Hanmi Pharm. Co., Ltd. (Korea), and Laboratorio Reig Jofre (Spain).

MarketsandMarkets™
Mr. Aashish Mehra
1-888-600-6441
raviraj.tak@marketsandmarkets.com

Source: EmailWire.Com



Source link

Share This Article
Facebook Email Copy Link Print

HOT NEWS

EPA’s Final Rule on TCE: Regulatory Freeze and Further Delays

Environmental Science
April 5, 2025

Boehringer Ingelheim puts China strategy into action with SBP deal

Boehringer Ingelheim and China’s SBP Group have entered a strategic multi-programme agreement with to advance…

November 9, 2026

Therapeutic Electrodes Market Projected to Grow at a CAGR of 6.2% During the Forecast Period 2021-2026

  Therapeutic Electrodes Market (I-BusinessNews.Com, August 04, 2021 ) The Therapeutic Electrodes Market size was…

August 4, 2021

Breast Imaging Market to reach USD 5.4 billion by 2025, at a CAGR of 8.1%

(I-BusinessNews.Com, August 05, 2021 ) The breast imaging market is projected to grow from an…

August 5, 2021

YOU MAY ALSO LIKE

Wound Care Market Forecasted to Reach USD 47.13 Billion By 2035, at an Impressive 6.4% CAGR

Wound Care Market Summary The global Wound Care Market is poised for significant expansion over the next decade, driven by…

Press Releases
March 18, 2026

Brain Health Supplements Market Forecast to Hit USD 40.65 Billion by 2034, with a Notable CAGR of 13.70%

 Brain Health Supplements Market Overview(PharmaNewsWire.Com, June 19, 2025 ) Brain Health Supplements Market Overview: The global brain health supplements market…

Press Releases
June 19, 2025

E-Waste Management Market Report Detailing Processed Materials and Application Segments with Long-Term Market Forecasts

 Segmentation of E-Waste Management Market(PharmaNewsWire.Com, May 20, 2025 ) InsightAce Analytic Pvt. Ltd. announces the release of a market assessment…

Press Releases
May 20, 2025

Ophthalmic Drugs Market is anticipated to reach USD 56.34 Million at a CAGR of 3.90% CAGR by 2035

 Ophthalmic Drugs Market Overview(PharmaNewsWire.Com, June 16, 2025 ) Ophthalmic Drugs Market: Comprehensive Analysis and Future OutlookThe global ophthalmic drugs market…

Press Releases
June 16, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

Boehringer Ingelheim puts China strategy into action with SBP deal
November 9, 2026
Two papers published online this week
November 9, 2026
Stop Testing AI Against Doctors. Test Doctors With AI. – The Health Care Blog
November 9, 2026
CAT ET3 Software French Language Support & How to Change Language – OBDII.SHOP OFFICIAL BLOG
November 9, 2026

Life Science Magazines

A New Blueprint: Innovations in DNA Synthesis
July 7, 2026
Inside HCP Decision-Making – The 2026 Access Landscape
July 6, 2026
Checklist for Submitting to an Institutional Review Board
July 2, 2026
Unlocking the Power of Primary Care in Cronic Disease Research
July 2, 2026

LS Newswire Service™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?